<SEC-DOCUMENT>0001104659-24-086369.txt : 20240807
<SEC-HEADER>0001104659-24-086369.hdr.sgml : 20240807
<ACCEPTANCE-DATETIME>20240806184446
ACCESSION NUMBER:		0001104659-24-086369
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240805
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240807
DATE AS OF CHANGE:		20240806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FENNEC PHARMACEUTICALS INC.
		CENTRAL INDEX KEY:			0001211583
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32295
		FILM NUMBER:		241180907

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 13628
		STREET 2:		68 TW ALEXANDER DRIVE
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709
		BUSINESS PHONE:		(919) 636-4530

	MAIL ADDRESS:	
		STREET 1:		PO BOX 13628
		STREET 2:		68 TW ALEXANDER DRIVE
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FENNEC PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20140903

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADHEREX TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20021223
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2421051d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:fencf="http://adherex.com/20240805">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_fencf_adherex.com_20240805 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240805_20240805 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001211583 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000004" name="dei:EntityCentralIndexKey">0001211583</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fencf-20240805.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-08-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001211583</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-05</xbrli:startDate>
        <xbrli:endDate>2024-08-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Form <span id="xdx_908_edei--DocumentType_c20240805__20240805_zAMlRdd83ZGh"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Current Report</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d) of the
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90B_edei--DocumentPeriodEndDate_c20240805__20240805_z3b2N4jq2Kdc"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 5, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityRegistrantName_c20240805__20240805_zrUW1QeVNWC9" style="font-size: 14pt"><b><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000011" name="dei:EntityRegistrantName">FENNEC
PHARMACEUTICALS INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityFileNumber_c20240805__20240805_zOehOUIbmMlg"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000012" name="dei:EntityFileNumber">001-32295</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 49%; font-size: 10pt; text-align: center"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20240805__20240805_zUrOziswBbqe"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt-sec:edgarprovcountryen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">British Columbia, Canada</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; width: 2%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 49%; font-size: 10pt; text-align: center"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20240805__20240805_z8UrshTGTJgl"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000014" name="dei:EntityTaxIdentificationNumber">20-0442384</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation)</p></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center">(I.R.S. Employer Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20240805__20240805_zspKz5s6hlMh"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000015" name="dei:EntityAddressAddressLine1">PO Box 13628</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20240805__20240805_zyGX1mpGGuV4"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000016" name="dei:EntityAddressAddressLine2">68 TW Alexander Drive</ix:nonNumeric></span>,</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20240805__20240805_zBZYV3GH8yp6"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000017" name="dei:EntityAddressCityOrTown">Research Triangle Park</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20240805__20240805_zy2b6uodLAZ8"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000018" name="dei:EntityAddressStateOrProvince">NC</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; width: 2%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20240805__20240805_zyqaaKGgBcx3"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000019" name="dei:EntityAddressPostalZipCode">27709</ix:nonNumeric></span></b></p></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center">(Address of principal executive offices)</td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code:</b> <b>(<span id="xdx_90F_edei--CityAreaCode_c20240805__20240805_zEMX5jsiC8Fd"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000020" name="dei:CityAreaCode">919</ix:nonNumeric></span>) <span id="xdx_90A_edei--LocalPhoneNumber_c20240805__20240805_zPmIH6DenKV6"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000021" name="dei:LocalPhoneNumber">636-4530</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90B_edei--WrittenCommunications_c20240805__20240805_zUgyOdW12U28"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule&#160;425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_907_edei--SolicitingMaterial_c20240805__20240805_zdu78k5CGCc4"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20240805__20240805_z3dzbxdWl9ye"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20240805__20240805_z8GlyWUwmSjh"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12 of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; width: 33%; padding-top: 1.1pt; padding-right: 1.1pt; padding-left: 1.1pt; text-align: center">Title of each class</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; width: 34%; padding-top: 1.1pt; padding-right: 1.1pt; padding-left: 1.1pt; text-align: center">Trading symbol(s)</td>
    <td style="border: black 1pt solid; white-space: nowrap; width: 33%; padding-top: 1.1pt; padding-right: 1.1pt; padding-left: 1.1pt; text-align: center">Name of each exchange on which&#8239;<br/>
registered</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 1.1pt; padding-right: 1.1pt; padding-left: 1.1pt; text-align: center"><span id="xdx_900_edei--Security12bTitle_c20240805__20240805_zrjQjKqMQAJ9"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000026" name="dei:Security12bTitle">Common shares, no par value</ix:nonNumeric></span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 1.1pt; padding-right: 1.1pt; padding-left: 1.1pt; text-align: center"><span id="xdx_908_edei--TradingSymbol_c20240805__20240805_zCVQGq3A01pa"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000027" name="dei:TradingSymbol">FENC</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 1.1pt; padding-right: 1.1pt; padding-left: 1.1pt; text-align: center"><span id="xdx_908_edei--SecurityExchangeName_c20240805__20240805_zQDEJjX9Rw3"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 56.1pt 0pt 13.2pt; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20240805__20240805_zn0bUiahzKXd"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.75in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#160;5.02.</b></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2024, Fennec Pharmaceuticals Inc.&#8217;s
(the "Company") announced the departure of Rostislav Raykov from his position as the Company&#8217;s Chief Executive Officer
(&#8220;CEO&#8221;). Mr. Raykov has served as CEO and a member of the Company&#8217;s board of directors (&#8220;Board&#8221;) for 15
years. Mr. Raykov will remain a member of the Company&#8217;s Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Mr. Raykov&#8217;s departure
as CEO, on August 5, 2024, the Company and Mr. Raykov entered into a Confidential Separation Agreement pursuant to which, among other
terms customary for an agreement of this type, the Company agreed to accelerate the vesting of certain options held by Mr. Raykov to purchase
up to 292,359 common shares of the Company at a weighted average price of $7.50. Mr. Raykov holds 148,609 restricted share units which
shall remain in full force and effect and will vest in accordance with the original terms when awarded, such that all shares will be released
from restriction by April 30, 2027.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
August 5, 2024, the Company announced the appointment of Jeffrey S. Hackman as CEO and a member of the Board. </span>There are no arrangements
or understandings between Mr. Hackman and any other person pursuant to which Mr. Hackman was appointed as CEO. Mr. Hackman has no family
relationships with any other executive officer or director of the Company. Mr. Hackman has not been involved in any related person transactions
with the Company that would require disclosure under Item 404(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Hackman, age 62, brings more than
30 years of commercial leadership experience to the Company, including oversight of more than 10 product launches across a wide range
of therapeutic areas and markets. His tenure in oncology spans the last 12 years across Sigma Tau, Baxalta, Shire, and EUSA Pharma, where
he was responsible for the U.S. commercial organizations and managing respective product portfolios in multiple franchises, which generated
billions in revenue over the years. More specifically, Mr. Hackman has successfully commercialized products that are specifically relevant
to the PEDMARK<sup>&#174;</sup> markets, including the outpatient oncology community and the AYA population.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Mr. Hackman&#8217;s
appointment to CEO, he entered into an employment agreement with the Company effective as of August 5, 2024. Mr. Hackman&#8217;s employment
agreement is an &#8220;at-will&#8221; agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the employment agreement, Mr. Hackman&#8217;s initial base annualized salary will be at a rate of $550,000, subject to
review and increase from time to time by the Company in its sole discretion. He shall be entitled to receive an annual target performance
bonus (the &#8220;<span style="text-decoration: underline">Target Bonus</span>&#8221;) of fifty percent (50%) of Mr. Hackman&#8217;s base salary per 12-month period (which may
be pro-rated for any partial period of less than 12&#160;months), based upon a determination by the Board of the achievement of objectives
to be set from time to time by the Board, provided that Mr. Hackman must remain employed through the payment date to be eligible to receive
the Target Bonus. In addition, the Company will grant Mr. Hackman 400,000 options to purchase common shares of the Company which (i) have
an exercise price per share equal to the &#8220;Fair Market Value&#8221; (as defined in Company&#8217;s 2020 Equity Incentive Plan); (ii)
have a term of ten years and one-third of which shall vest one year after the date of the grant and the balance thereof shall vest monthly
thereafter for two years in equal increments, and (iii) are otherwise subject to the terms and conditions set forth in the Company&#8217;s
</span>2020 Equity Incentive <span style="font-size: 10pt">Plan. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Hackman&#8217;s employment agreement
generally provides that if his employment is terminated without &#8220;Cause&#8221; (as defined in the employment agreement) and other
conditions are satisfied, then Mr. Hackman shall receive as severance an amount equal to his then current base salary for a period of
twelve (12) months, less standard withholdings for tax and social security purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.4pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Confidential
Separation Agreement is qualified by the complete text of the Confidential Separation Agreement, a copy of which is attached at Exhibit&#160;10.1
to this Current Report on Form 8-K and is incorporated by reference herein. The foregoing description of the Executive Employment Agreement
is qualified by the complete text of the Executive Employment Agreement, a copy of which is attached as Exhibit 10.2 to this Current Report
on Form 8-K and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.75in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 8.01</b></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Items.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2024, the Company issued a press
release announcing Mr. Raykov&#8217;s departure as the Company&#8217;s CEO and Mr. Hackman&#8217;s appointment as CEO and a member of
the Board. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in this Item 8.01, including
the press release attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section&#160;18 of the Securities
Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), or incorporated by reference into any filing under the Securities Act of 1933 or
the Exchange Act, unless such subsequent filing specifically references this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.75in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.8pt; text-indent: -41.8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.75in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Exhibit No.</span></span></td>
    <td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Description</span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="tm2421051d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 99.1</span></a></td>
    <td><a href="tm2421051d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated August 5, 2024</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="tm2421051d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 10.1</span></a></td>
    <td><a href="tm2421051d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential Separation Agreement between the Company and Rostislav Raykov, effective as of August 5, 2024</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="tm2421051d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 10.2</span></a></td>
    <td><a href="tm2421051d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Employment Agreement between the Company and Jeffrey S. Hackman, effective as of August 5, 2024</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 27.35pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FENNEC PHARMACEUTICALS INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date August 6, 2024</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert Andrade</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Robert Andrade <br/>
Chief Financial Officer</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk2DBembFhWxihQRX6PdSrDNlk38O5K3NLaIy8KyzHwzQgzEkhamRobjrMhhj01ba49QYIWM9ozBka3WKYRb4MU4z9r67v2BGQUGA5MMlToFobPejcMyBZmM5GSkxhDLNJEw3Yjoq2dkK1Oi9UbXoG0JO6aWDXrNrz5hr59kqXl1VQdkZ8imEA9lL79ByVjBlu76QXx1kOeZiAbdRGLJdGuDa/70aL8kzGtsQp3r6f9GH/3PSn0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2421051d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>CONFIDENTIAL SEPARATION
AGREEMENT </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">THIS
CONFIDENTIAL SEPARATION AGREEMENT</FONT> (the &ldquo;<B>Agreement</B>&rdquo;) is made and entered into on August ___, 2024 by and among
Rostislav Raykov (the &ldquo;<B>Executive</B>&rdquo;) and Fennec Pharmaceuticals, Inc., a Delaware corporation (&ldquo;<B>Fennec US</B>&rdquo;),
Fennec Pharmaceuticals Inc., a British Columbia corporation (&ldquo;<B>Parent</B>&rdquo;) (Fennec US, Parent and their respective affiliated
corporations, predecessors, and successors are collectively referred to herein as the &ldquo;<B>Company</B>&rdquo;). The Executive and
the Company are sometimes referred to collectively as the &ldquo;<B>Parties</B>&rdquo; and individually as a &ldquo;<B>Party</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B><U>RECITALS</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5pt; text-align: justify; text-indent: 35.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
the Executive is employed by Fennec US pursuant to an employment agreement dated May 3, 2010 (the &ldquo;<B>Employment Agreement</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5pt; text-align: justify; text-indent: 35.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AND
WHEREAS</B></FONT> the Company and the Executive mutually wish for Executive&rsquo;s employment with the Company to cease effective on
the close of business on August 4th, 2024 (the &ldquo;<B>Effective Date</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5pt; text-align: justify; text-indent: 35.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AND
WHEREAS</B></FONT>, the Parties wish to confirm their respective rights and obligations in connection with the foregoing cessation of
the Executive&rsquo;s employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-indent: 36.05pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B><U>AGREEMENT</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NOW
THEREFORE</B></FONT>, in consideration of and in exchange for the promises and covenants contained in this Agreement and the valuable
consideration described herein, the sufficiency of which is hereby acknowledged by the Parties, the Parties mutually agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B><U>Separation Arrangements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Cessation of Employment</U>. </I>Executive and Company hereby agree and confirm that Executive&rsquo;s employment shall end
effective as of the Effective Date. Executive hereby agrees to resign as Chief Executive Officer (as well as any other officer position
with any Company entity) on the day following the certification and filing of the Parent&rsquo;s consolidated interim financial statements
for the period ended June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Continuation as Board Member</U></I>. Notwithstanding clause (a) of this Section 1, the Parties agree that Executive shall
<U>not</U> be resigning from the board of directors of Parent (the &ldquo;<B>Board</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT> <I><U>Remuneration and Vacation Up to Effective Date</U></I>. The Company shall pay to the Executive his normal salary, less usual
deductions for federal, state and local payroll taxes and other withholdings, up to and including the Effective Date in accordance with
the Company&rsquo;s normal payroll procedures. The <I>pro rata</I> portion of the Executive&rsquo;s annual vacation entitlement that has
not been taken prior to the Effective Date shall also be paid in accordance with the Company&rsquo;s normal payroll procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Expense Reimbursement</U></I>. Executive will be reimbursed for all customary, ordinary and necessary business expenses incurred
by Executive in the performance of Executive&rsquo;s duties up to the Effective Date, all in accordance with the Employment Agreement
and Company policies, provided Executive furnishes the Company with vouchers, receipts and other details of such expenses prior to the
date that is ninety (90) days after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Additional Payments</U></I>. The Company shall also pay to Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>an
amount equal to Executive&rsquo;s current Base Salary, less usual deductions for federal, state and local payroll taxes and other withholdings,
for a period of one (1) year, which amount shall be paid within five (5) days of the Effective Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
<I>pro rata</I> share of the Executive&rsquo;s Annual Bonus (but only to the extent actually earned by Executive) not paid prior to the
Effective Date, which shall be paid, less usual deductions for federal, state and local payroll taxes and other withholdings, after the
2024 fiscal year in accordance with the Company&rsquo;s usual practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt 0pt 0.5in; text-align: justify; text-indent: 0.3pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt 0pt 0.5in; text-align: justify; text-indent: 0.3pt"><I></I></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt 0pt 0.5in; text-align: justify; text-indent: 0.3pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I><U>Options/RSUs</U></I>. The Parties acknowledge and confirm that, as of the Effective Date, the Executive will, assuming no
intervening exercises between now and then, hold the options and restricted stock units set forth in <U>Schedule &ldquo;A&rdquo;</U>.
By remaining on the Board, the Parties confirm that the Executive remains a &ldquo;<I>Participant</I>&rdquo;, as such term is defined
in the Parent&rsquo;s Amended and Restated Stock Option Plan (the &ldquo;<B>Original Plan</B>&rdquo;), and in a &ldquo;<I>Service Relationship</I>&rdquo;
as such term is defined in Parent&rsquo;s 2020 Equity Incentive Plan (the &ldquo;<B>2020 Plan</B>&rdquo;). Accordingly, the options and
RSUs set forth in <U>Schedule &ldquo;A&rdquo;</U> shall not be terminated in connection with the Executive&rsquo;s change in status from
an employee to a Board member and shall remain in in full force and effect in accordance with their respective terms and the Company plan
under which they were granted (i.e. either Original Plan or the 2020 Plan, as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Vesting / Exercise Period</U></I>. The Company agrees to accelerate the vesting of all options set forth in <U>Schedule &ldquo;A&rdquo;</U>
which by their terms have not vested as of the Effective Date. The RSUs shall vest in accordance with their original terms. All options
set forth in <U>Schedule &ldquo;A&rdquo;</U> shall remain exercisable until the earliest of: (i) their original respective date of expiry
(as set forth in the column entitled <I>Original Expiry Date, </I>where applicable); (ii) the third anniversary of the date on which Executive
no longer serves on the Board and is otherwise no longer a Participant or in a Service Relationship with the Company; or (iii) termination
in connection with a Change in Control (as such term is defined in the Original Plan) or a Sale Event (as such term is defined in the
2020 Plan), as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I><U>COBRA
Benefits</U></I>. Executive&rsquo;s existing coverage under the Company&rsquo;s group health plan (and, if applicable, the existing group
health coverage for his or her eligible dependents) will end on the last day of August, 2024. Executive and his or her eligible dependents
may then be eligible to elect temporary continuation coverage under the Company&rsquo;s group health plan in accordance with the Consolidated
Omnibus Budget Reconciliation Act of 1985, as amended (&ldquo;<B>COBRA</B>&rdquo;). Executive and his eligible dependents has been provided
with a COBRA election form and notice which describe his rights to continuation coverage under COBRA. If Executive timely elects COBRA
continuation coverage, then the Company will pay for COBRA coverage for him and, if applicable, his eligible dependents until the earliest
of (i) the date that is twelve months after the Effective Date; (ii) the date when the Executive becomes eligible for health insurance
coverage in connection with new employment or self-employment; or (iii) the date the Executive ceases to be eligible for COBRA continuation
coverage for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I><U>Other Benefits</U></I>. Other than as specifically provided above in this Section 1, Executive&rsquo;s participation in any
and all other Company employee benefit plans (including without limitation under the Parent&rsquo;s Management M&amp;A Incentive Plan
dated November 15, 2022, as amended (the &ldquo;<B>M&amp;A Incentive Plan</B>&rdquo;)) shall cease on the Effective Date. The Executive
hereby consents to the termination of the M&amp;A Incentive Plan. Further, in consideration of the benefits provided to the Executive
under this Section 1, Executive agrees that he will not be granted any additional options or receive any additional cash fees for serving
on the Board until the next annual election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I><U>Release</U></I>. The consideration provided to Executive in clauses (e), (f), (g) and (h) of this Section 1 are conditional
upon Executive signing and delivering this Agreement and not revoking the Release, as defined in Section 2 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B><U>Acknowledgements and Release</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Acknowledgements</U></I>. The Executive acknowledges and agrees that he does not have any right to: (i) receive any cash
payments from the Company other than as set forth in clauses (c), (d), (e) and (h) of Section 1 above; (ii) receive, acquire, possess,
or vest into any additional stock options, shares, or restricted stock units, or any other shares, warrants, securities, derivative securities,
or other class of capital stock of the Company other than as set forth in clause (f) and (g) of Section 1 above; or (iii) receive any
other benefits other than as set forth in clause (h) of Section 1. The Executive hereby also acknowledges that he fully understands the
terms of this Agreement, and has had the opportunity to receive independent legal representation in connection with the entering into
this Agreement, and voluntarily accepts the payments and other benefits herein in consideration for the release set forth in subsection
2(b) below (the &ldquo;<B>Release</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Release</U></I>. The Executive, for himself or anyone who may have a claim by or through him, and for his heirs, estate,
executors, administrators, successors and assigns, hereby releases, acquits and forever discharges the Company, as well as each of the
Company&rsquo;s respective affiliates, parents, subsidiaries and related entities, officers, directors, shareholders, members, employees
(past and present), professional employer organizations, as well as the Company&rsquo;s insurers, reinsurers, agents, servants, representatives,
attorneys, and assigns, and any and all other entities with whom the Company has been, are now, or may hereafter be affiliated (collectively
 &ldquo;<B>Releasees</B>&rdquo;), from any and all claims, demands, obligations, actions, causes of action, liabilities, debts, promises,
agreements, demands, attorneys&rsquo; fees, losses and expenses, known or unknown, suspected or unsuspected, filed or unfiled, that Executive
may have or have had arising out of any known or unknown fact, condition or incident occurring prior to the date of this Agreement, including
but not limited to those arising out of or in connection with Executive&rsquo;s employment, the cessation thereof, or any other interaction
or relations with Releasees relating to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><I><U>Understanding Respecting Release</U></I>. It is understood and agreed that: (i) both the Release and any consideration transferred
hereunder are deemed to be no admission whatsoever of liability on the part of the Releasees; and (ii) the Release shall <U>not</U> apply
to the Company&rsquo;s obligations set forth in this Agreement, nor to the Executive&rsquo;s continued right to indemnification as an
officer and/or director of any Company entity up to the Effective Date, including any actions taken in such positions up to the Effective
Date, nor to the Executive&rsquo;s continued right to indemnification as a director of Parent after the Effective Date, all as provided
in Company constating documents and associated director and officer insurance policies of the Company; (iii) the Release shall enure to
the benefit of the Releasees and shall be binding on the Executive as well as the Executive&rsquo;s heirs, representatives, successors
and assigns; and (iv) the Release is not a condition for the Executive to receive any money to which the Executive would otherwise be
entitled to by operation of statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt 0pt 0.5in; text-align: justify; text-indent: 0.3pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>No
Representations Regarding Tax Consequences</U></B>. The Executive understands and agrees that he (and not any Releasee) is solely responsible
for payment of any taxes which are required to be paid to any governmental entity as a result of the Executive&rsquo;s receipt of any
of the consideration set forth in this Agreement, including but not limited to: (i) the options referred to in clauses (f) and (g) of
Section 1, and the exercise thereof; and (ii) the RSUs referred to in clauses (f) and (g) of Section 1, and the vesting thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Continuing
Obligations</U>.</B> Executive acknowledges and agrees that certain of Executive&rsquo;s obligations under the Proprietary Information
and Inventions Agreement signed by him continue after the Effective Date. These obligations include, but may not be limited to, obligations
of confidentiality and obligations relating to any intellectual property to which Executive may have contributed while employed by the
Company. Executive also acknowledges his continuing fiduciary obligations as a member of the Board. The Parties agree that, if a Sale
Event has not occurred and, despite Executive remaining willing and able to serve on the Board, the Executive is not re-elected to the
Board at the next annual meeting of shareholders, the Company may retain the Executive as an independent consultant. Any services provided
by the Executive, and any remuneration therefor, under such independent consulting agreement shall be on a project-by-project basis, as
may be agreed between the parties thereto at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Miscellaneous</U></B><U>.</U>
This Agreement shall be interpreted under the laws of North Carolina, both as to interpretation and performance. This Agreement constitutes
the entire agreement between the Parties regarding the Executive&rsquo;s resignation and the cessation of Executive&rsquo;s employment
with the Company and supersedes all prior agreements, written or oral, between the Company and the Executive regarding such resignation
and cessation of employment, and no other agreement, statement, or promise made by one Party to another as to any matter addressed in
this Agreement shall be binding or valid. This Agreement cannot be orally modified. Any amendment or modification to this Agreement must
be in writing, signed by the Executive and by a duly authorized representative of the Company. This Agreement, and all the terms and provisions
contained herein, shall bind the heirs, personal representatives, successors and assigns of each Party, and inure to the benefit of each
Party, its agents, directors, officers, employees, servants, successors, and assigns. This Agreement is the product of arms-length negotiations
and is considered to be jointly drafted. As such, it shall not be construed against any Party because that Party caused it to be reduced
to a written instrument. The Parties agree that the terms of this Agreement are fair, reasonable and adequate and the Parties covenant
never to challenge this Agreement. The failure of any Party to insist upon compliance with any term, covenant or condition contained in
this Agreement shall not be deemed a waiver of that term, covenant or condition, nor shall any waiver or relinquishment of any right or
power contained in this Agreement at any one time or more times be deemed a waiver or relinquishment of any right or power at any other
time or times. This Agreement may be executed in any number of counterparts, each of which will be deemed to be an executed Agreement
and each of which shall be deemed to be one and the same instrument. A facsimile or digital signature shall be treated as an original
signature for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AGREED as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-indent: 35.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Rostislav Raykov</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">FENNEC PHARMACEUTICALS, INc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Khalid Islam</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">FENNEC PHARMACEUTICALS INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Khalid Islam</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2421051d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXECUTIVE EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS EXECUTIVE EMPLOYMENT
AGREEMENT (the &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into the 5th day of August, 2024 by and between FENNEC PHARMACEUTICALS,&nbsp;INC.,
a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), and JEFF HACKMAN (the &ldquo;<B><I>Executive</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS the Company desires
to employ the Executive in the capacity of full-time Chief Executive Officer pursuant to the terms of this Agreement and, in connection
therewith, to compensate the Executive for Executive&rsquo;s personal services to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AND WHEREAS the Executive
wishes to be employed by the Company and provide personal services to the Company in return for certain compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the mutual promises and covenants contained herein, the parties agree to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>EMPLOYMENT
BY THE COMPANY</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>At-Will Employment</U></B>. Executive shall be employed by the Company on an &ldquo;at-will&rdquo; basis, meaning either the Company
or Executive may terminate Executive&rsquo;s employment at any time, with or without cause or advanced notice.&nbsp; Any contrary representations
that may have been made to Executive shall be superseded by this Agreement.&nbsp; This Agreement shall constitute the full and complete
agreement between Executive and the Company on the &ldquo;at-will&rdquo; nature of Executive&rsquo;s employment with the Company, which
may be changed only in an express written agreement signed by Executive and a duly authorized officer of the Company. Executive&rsquo;s
rights to any compensation following a termination shall be only as set forth in Section&nbsp;6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Position</U></B>.&nbsp; Subject to the terms set forth herein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>the
Company agrees to employ Executive, and Employee hereby accepts such employment, commencing on August 5, 2024 (the &ldquo;<B><I>Start
Date</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 56.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>the
Company shall appoint Executive as the Chief Executive Officer and as member of the board of directors, and Executive hereby accepts
such appointments, effective as of the day following the certification and filing of the consolidated interim financial statements of
the Company&rsquo;s parent, Fennec Pharmaceuticals Inc., a British Columbia corporation (the &ldquo;<B><I>Parent</I></B>&rdquo;), for
the period ended June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the term of Executive&rsquo;s employment
with the Company, Executive will devote Executive&rsquo;s best efforts and substantially all of Executive&rsquo;s business time and attention
to the business of the Company. Executive will also be appointed Chief Executive Officer and member of the Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;)
of the Parent effective on the date referred to in subsection 1.2(ii) above</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.3</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Duties</U></B>.&nbsp; Executive will report to the Board, performing such duties as are normally associated with his position and
such duties as are assigned to him from time to time, subject to the oversight and direction of the Board, or the Compensation Committee
thereof.&nbsp; Executive shall perform his duties under this Agreement principally out of Boston Metro Area.&nbsp; In addition, the Executive
shall make such business trips to such places as may be necessary or advisable for the efficient operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.4</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Company Policies and Benefits</U></B>.&nbsp; The employment relationship between the parties shall also be subject to the Company&rsquo;s
personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company&rsquo;s sole
discretion.&nbsp; The Executive will be eligible to participate on the same basis as similarly situated employees in the Company&rsquo;s
benefit plans in effect from time to time during his employment.&nbsp; All matters of eligibility for coverage or benefits under any benefit
plan shall be determined in accordance with the provisions of such plan.&nbsp; The Company reserves the right to change, alter, or terminate
any benefit plan in its sole discretion.&nbsp; Notwithstanding the foregoing, in the event that the terms of this Agreement differ from
or are in conflict with the Company&rsquo;s general employment policies or practices, this Agreement shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.5</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Paid Time Off</U></B>.&nbsp; The Executive will be eligible for up to twenty (20) days of paid time off per calendar year in accordance
with any paid leave policy adopted by the Company from time to time.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>COMPENSATION</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Salary</U></B>.&nbsp; Executive shall receive for Executive&rsquo;s services to be rendered hereunder an initial annualized base
salary of US$550,000 per year, subject to review and increase from time to time by the Company in its sole discretion, payable subject
to standard federal and state payroll withholding requirements in accordance with Company&rsquo;s standard payroll practices (&ldquo;<B><I>Base
Salary</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Bonus</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>During Employment</U></B>. Executive shall be eligible to earn an annual target performance bonus of 50% of his Base Salary (&ldquo;<B><I>Annual
Bonus</I></B>&rdquo;).&nbsp; The Annual Bonus, which may be more or less than the target Annual Bonus will be based upon the assessment
of the Executive&rsquo;s performance by the Board and the Company&rsquo;s attainment of targeted goals as set by the Board in its discretion
after consultation with Executive.&nbsp; The Annual Bonus, if any, will be subject to applicable payroll deductions and withholdings.&nbsp;
Following the close of each calendar year, the Board will determine whether the Executive has earned the Annual Bonus, and the amount
of any Annual Bonus, based on the set criteria.&nbsp; No amount of the Annual Bonus is guaranteed, and except as provided in Sections
6.1 and 6.4 below, the Executive must be an employee in good standing on the Annual Bonus payment date to be eligible to receive an Annual
Bonus; no partial or prorated bonuses will be provided.&nbsp; The Annual Bonus, if earned, will be paid no later than March&nbsp;15th
of the calendar year immediately following the applicable calendar year for which the Annual Bonus is being measured.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Upon Termination</U></B>.&nbsp; Except as provided in Sections 6.1 and 6.4 below, in the event Executive leaves the employ of the
Company for any reason prior to payment of any bonus, he is not eligible for such bonus, prorated or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Stock Options</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Option Grant</U></B>.&nbsp; Executive will be granted options to purchase 400,000 common shares in the capital of the Parent (subject
to adjustment for stock splits, dividends and combinations and similar events as will be set forth in the option agreement), with a 10-year
term, pursuant and subject to the Parent&rsquo;s 2020 Equity Incentive Plan (&ldquo;<B><I>Plan</I></B>&rdquo;) and the Parent&rsquo;s
standard form of Stock Option Agreement (&ldquo;<B><I>Stock Agreement</I></B>&rsquo;) between the Executive and the Parent (the &ldquo;<B><I>Option</I></B>&rdquo;).&nbsp;&nbsp;
The Option will have an exercise price per share equal to the fair market value of a common share in the capital of the Parent, to be
determined in accordance with the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Vesting</U></B>.&nbsp; The Option shall vest over a period of three years as follows: (i)&nbsp;33 1/3%% of the total shares subject
to the Option shall vest on the first anniversary of the Start Date, and (ii)&nbsp;1/24</FONT><FONT STYLE="font-size: 10pt">th</FONT>&nbsp;of
total shares subject to the Option shall vest monthly thereafter over the remaining two years of the vesting period, subject to Executive&rsquo;s
continuous service as of each applicable date.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Expense Reimbursement</U></B>.&nbsp; The Company will reimburse Executive for all reasonable, documented business expenses incurred
in connection with his services hereunder, in accordance with the Company&rsquo;s business expense reimbursement policies and procedures
as may be in effect from time to time. In addition, the Company shall pay up to $5,000 of the reasonable attorney&rsquo;s fees incurred
by Executive in connection with the negotiation and documentation of this Agreement and any related agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.5</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Indemnification</U></B>. The Executive shall be entitled to indemnification to the maximum extent permitted by applicable law and
the Company&rsquo;s bylaws with terms no less favorable than provided to any other Company executive officer.&nbsp; At all times during
the Executive&rsquo;s employment, the Company shall maintain in effect a directors and officers liability insurance policy with the Executive
as a covered officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>PROPRIETARY
INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT</U></B>.&nbsp; The parties hereto have entered into a Proprietary Information and Inventions
Assignment Agreement (the &ldquo;<B><I>Proprietary Information Agreement</I></B>&rdquo;), which may be amended by the parties from time
to time without regard to this Agreement.&nbsp; The Proprietary Information Agreement contains provisions that are intended by the parties
to survive and do survive termination or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>OUTSIDE ACTIVITIES</U></B>.&nbsp; Except with the prior written consent of the Company&rsquo;s Board, Executive will not, while
employed by the Company, undertake or engage in any other employment, occupation or business enterprise that would interfere with Executive&rsquo;s
responsibilities and the performance of Executive&rsquo;s duties hereunder except for (i)&nbsp;reasonable time devoted to volunteer services
for or on behalf of such religious, educational, non-profit and/or other charitable organization as Executive may wish to serve; (ii)&nbsp;reasonable
time devoted to activities in the non-profit and business communities consistent with Executive&rsquo;s duties; (iii)&nbsp;reasonable
time devoted to service on boards of directors of companies that are not competitive with the Company, do not otherwise present a conflict
of interest and would not otherwise interfere with Executive&rsquo;s responsibilities and the performance of Executive&rsquo;s duties
hereunder, subject to the prior written approval of the Board (which approval shall not be unreasonably withheld); and (iv)&nbsp;such
other activities that would not interfere with Executive&rsquo;s responsibilities and the performance of Executive&rsquo;s duties hereunder
as may be specifically approved by the Board (which approval shall not be unreasonably withheld).&nbsp; This restriction shall not, however,
preclude the Executive from owning less than one percent (1%) of the total outstanding shares of a publicly traded company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>NO CONFLICT WITH EXISTING OBLIGATIONS</U></B>.&nbsp; Executive represents that Executive&rsquo;s performance of all the terms of
this Agreement and as an employee of the Company do not and will not breach any agreement or obligation of any kind made prior to Executive&rsquo;s
employment by the Company, including agreements or obligations Executive may have with prior employers or entities for which Executive
has provided services.&nbsp; Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement or
obligation, either written or oral, in conflict herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>TERMINATION
OF EMPLOYMENT</U></B></FONT>.&nbsp; The parties acknowledge that Executive&rsquo;s employment relationship with the Company is at-will.&nbsp;
Either Executive or the Company may terminate the employment relationship at any time, with or without Cause.&nbsp; The provisions in
this Section&nbsp;govern the amount of compensation, if any, to be provided to Executive upon termination of employment and do not alter
this at-will status.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Termination by the Company Without Cause</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The Company shall have the right to terminate Executive&rsquo;s employment with the Company pursuant to this Section&nbsp;6.1 at any time
without &ldquo;Cause&rdquo; (as defined in Section&nbsp;6.2(a)&nbsp;below) by giving notice as described in Section&nbsp;6.6 of this Agreement.&nbsp;
A termination pursuant to Section&nbsp;6.4 below is not a termination without &ldquo;Cause&rdquo; for purposes of receiving the benefits
described in this Section&nbsp;6.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except as otherwise provided in this Section 6.1, upon termination of this Agreement for any reason, Executive shall not be entitled to
any form of severance benefits, including benefits otherwise payable under any of Company&rsquo;s regular severance plans or policies,
or any other payment whatsoever. Executive agrees that (i) the payment of any severance or other benefits pursuant to this Section 6.1
shall be contingent on the delivery by Executive to Company of a release and waiver of legal claims related to the employment relationship
between Executive and Company in a form reasonably acceptable to Company (the &ldquo;<B><I>Release</I></B>&rdquo;) and (ii) the payments
and benefits provided hereunder, subject to the terms and conditions hereof, shall be in full satisfaction of any rights which he might
otherwise have or claim by operation of law, by implied contract or otherwise. When the Release becomes effective and may no longer be
revoked by the Executive (the &ldquo;<B><I>Release Date</I></B>&rdquo;), then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the Company shall pay to Executive an amount equal to Executive&rsquo;s then current Base Salary for a period of twelve (12) months (the
 &ldquo;<B><I>Severance Period</I></B>&rdquo;), less applicable withholdings and deductions (such twelve (12) months of Base Salary, less
applicable withholdings and deductions, the &ldquo;<B><I>Severance Payment</I></B>&rdquo;), in installments in accordance with the Company&rsquo;s
ordinary payroll practices commencing on the Company&rsquo;s first regular payroll date that is more than sixty (60) days following the
Separation Date (as defined below), and shall be for any accrued Base Salary for the sixty (60) day period plus the period from the sixtieth
(60</FONT><FONT STYLE="font-size: 10pt">th</FONT>) day until the regular payroll date, if applicable, and all salary continuation payments
thereafter, if any, shall be made on the Company&rsquo;s regular payroll dates, until such time as the Severance Payment is paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the Separation Date occurs after the end of the prior fiscal year of the Company and before the payment date for the Annual Bonus relating
to that fiscal year, the Company shall pay to Executive such Annual Bonus, to the extent earned, on the same date as annual bonuses for
the fiscal year are paid to other senior executives of the Company (the &ldquo;<B><I>Prior Year Annual Bonus</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if the Executive timely elects continued coverage under COBRA for himself and his covered dependents under the Company&rsquo;s group health
plans following such termination, then the Executive will be entitled to the following COBRA benefits (the &ldquo;<B><I>COBRA Benefits</I></B>,&rdquo;
together with the Severance Payment and the Prior Year Annual Bonus (to the extent earned), the &ldquo;<B><I>Severance Benefits</I></B>&rdquo;):&nbsp;
the Company shall pay the COBRA premiums necessary to continue the Executive&rsquo;s and his covered dependents&rsquo; health insurance
coverage in effect for himself (and his covered dependents) on the termination date until the earliest of (x)&nbsp;a number of months
following the termination date equal to the Severance Period (the &ldquo;<B><I>COBRA Severance Period</I></B>&rdquo;); (y)&nbsp;the date
when the Executive becomes eligible for health insurance coverage in connection with new employment or self-employment; or (iii)&nbsp;the
date the Executive ceases to be eligible for COBRA continuation coverage for any reason, including plan termination (such period from
the termination date through the earlier of (i)-(iii), the &ldquo;<B><I>COBRA Payment Period</I></B>&rdquo;).&nbsp; Notwithstanding the
foregoing, if at any time the Company determines that its payment of COBRA premiums on the Executive&rsquo;s behalf would result in a
violation of applicable law, then in lieu of paying COBRA premiums pursuant to this Section, the Company shall pay the Executive on the
last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such month,
subject to applicable tax withholding (such amount, the &ldquo;<B><I>Special Severance Payment</I></B>&rdquo;), such Special Severance
Payment to be made without regard to the Executive&rsquo;s payment of COBRA premiums and without regard to the expiration of the COBRA
period prior to the end of the COBRA Payment Period.&nbsp; Nothing in this Agreement shall deprive the Executive of his rights under COBRA
or ERISA for benefits under plans and policies arising under his employment by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive shall not receive the Severance Benefits pursuant to Section&nbsp;6.1(b)&nbsp;unless he executes the Release within the consideration
period specified therein, which shall in no event be more than sixty (60) days, and until the Release becomes effective and can no longer
be revoked by Executive under its terms.&nbsp; Executive&rsquo;s ability to receive benefits pursuant to Section&nbsp;6.1(b)&nbsp;is further
conditioned upon his:&nbsp; (i) returning all Company property; (ii) complying with his post-termination obligations under this Agreement
and the Proprietary Information Agreement; and (iii) complying with the Release including, without limitation, customary non-disparagement
and confidentiality provisions contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The benefits provided to Executive pursuant to this Section&nbsp;6.1 are in lieu of, and not in addition to, any benefits to which Executive
may otherwise be entitled under any Company severance plan, policy or program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The damages caused by the termination of Executive&rsquo;s employment without Cause would be difficult to ascertain; therefore, the severance
for which Executive is eligible pursuant to Section&nbsp;6.1(b)&nbsp;above in exchange for the Release is agreed to by the parties as
liquidated damages, to serve as full compensation, and not a penalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Termination by the Company for Cause</U></B>.&nbsp; Subject to Section&nbsp;6.2(b)&nbsp;below, the Company shall have the right
to terminate Executive&rsquo;s employment with the Company at any time for Cause by giving notice as described in this Section&nbsp;6.2
and in Section&nbsp;6.5 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Cause</I></B>&rdquo; for termination shall mean the occurrence of any of the following: (i)&nbsp;Executive&rsquo;s conviction
of any felony or any crime involving fraud or dishonesty; (ii)&nbsp;Executive&rsquo;s participation in a fraud, act of dishonesty or other
act of gross misconduct that adversely affects the Company; (iii)&nbsp;conduct by Executive that demonstrates Executive&rsquo;s gross
unfitness to serve under circumstances that materially and adversely affect the Company; (iv)&nbsp;Executive&rsquo;s violation of any
statutory or fiduciary duty, or duty of loyalty, owed to the Company; (v)&nbsp;Executive&rsquo;s material breach of any material term
of any contract between such Executive and the Company; and/or (vi)&nbsp;Executive&rsquo;s serious violation of a material Company policy.
Prior to termination for Cause pursuant to each event listed in (iii)&nbsp;and (iv)&nbsp;above, the Company shall give the Executive notice
of such event(s), which notice shall specify in reasonable detail the circumstances constituting Cause, and an opportunity to explain
the circumstances.&nbsp; Prior to any termination for Cause pursuant to each event listed in (v)&nbsp;and (vi)&nbsp;above, to the extent
such event(s)&nbsp;is (are) capable of being cured by Executive, (A)&nbsp;the Company shall give the Executive notice of such event(s),
which notice shall specify in reasonable detail the circumstances constituting Cause, and an opportunity to cure, and (B)&nbsp;there shall
be no Cause with respect to any such event(s)&nbsp;if the Board determines in good faith that such events have been cured by Executive
within fifteen (15) days after the delivery of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In the event Executive&rsquo;s employment is terminated at any time for Cause, Executive will not receive the Severance Benefits described
in Section&nbsp;6.1(b), or any other severance compensation or benefit, except that, pursuant to the Company&rsquo;s standard payroll
policies, the Company shall pay to Executive the accrued but unpaid salary of Executive through the date of termination and unreimbursed
business expenses, together with all compensation and benefits payable to Executive based on his participation in any compensation or
benefit plan, program or arrangement through the date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.3</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Resignation by the Executive</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive may resign from Executive&rsquo;s employment with the Company at any time by giving notice as described in Section&nbsp;6.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In the event Executive resigns from Executive&rsquo;s employment with the Company, Executive will not receive the Severance Benefits,
or any other severance compensation or benefit, except that, pursuant to the Company&rsquo;s standard payroll policies, the Company shall
pay to Executive the accrued but unpaid salary of Executive through the date of resignation, any unreimbursed business expenses, together
with all compensation and benefits payable to Executive through the date of resignation under any compensation or benefit plan, program
or arrangement during such period and Executive shall be eligible for any benefit continuation or conversion rights provided by the provisions
of a benefit plan or by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.4</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Termination by Virtue of Death or Disability of the Executive</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In the event of Executive&rsquo;s death while employed pursuant to this Agreement, all obligations of the parties hereunder shall terminate
immediately, and the Company shall, pursuant to the Company&rsquo;s standard payroll policies, pay to the Executive&rsquo;s legal representatives
Executive&rsquo;s accrued but unpaid salary through the date of death, the unreimbursed business expenses, together with all compensation
and benefits payable to Executive based on his participation in any compensation or benefit plan, program or arrangement through the date
of termination. In addition, the Company shall pay to the Executive&rsquo;s legal representatives the Prior Year Annual Bonus, to the
extent earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject to applicable state and federal law, the Company shall at all times have the right, upon written notice to the Executive, to terminate
this Agreement based on the Executive&rsquo;s Disability (as defined below).&nbsp; Termination by the Company of the Executive&rsquo;s
employment based on &ldquo;<B><I>Disability</I></B>&rdquo; shall mean termination because the Executive is unable due to a physical or
mental condition to perform the essential functions of his position with or without reasonable accommodation for six (6)&nbsp;months in
the aggregate during any twelve (12) month period or based on the written certification by a licensed physician of the likely continuation
of such condition for such period.&nbsp; This definition shall be interpreted and applied consistent with the <I>Americans with Disabilities
Act</I>, the <I>Family and Medical Leave Act</I>, and other applicable law. In the event Executive&rsquo;s employment is terminated based
on the Executive&rsquo;s Disability, Executive will not receive the Severance Benefits, or any other severance compensation or benefit,
except that, pursuant to the Company&rsquo;s standard payroll policies, the Company shall pay to Executive the accrued but unpaid salary
of Executive through the date of termination, unreimbursed business expenses, together with all compensation and benefits payable to Executive
based on his participation in any compensation or benefit plan, program or arrangement through the date of termination. In addition, the
Company shall pay to Executive the Prior Year Annual Bonus, to the extent earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.5</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Notice; Effective Date of Termination</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Termination of Executive&rsquo;s employment (the &ldquo;<B><I>Separation Date</I></B>&rdquo;) pursuant to this Agreement shall be effective
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;ten (10)&nbsp;days after the Company has provided Executive with written notice of Executive&rsquo;s termination without Cause under Section&nbsp;6.1;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;for a termination for Cause:&nbsp; (1) under Section&nbsp;6.2(a)(i)&nbsp;or (ii), immediately upon provision by the Company of written
notice of the reasons to Executive; (2) under Section&nbsp;6.2(a)(iii)&nbsp;or (iv), following the required written notice to Executive
and expiration of the period during which Executive may explain; (3) under Section&nbsp;6.2(a)(v)&nbsp;or (vi),&nbsp; following the required
written notice to Executive and expiration of the 15-day cure period, if Executive has not cured;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
immediately upon the Executive&rsquo;s death;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
thirty (30) days after the Company gives notice to Executive of Executive&rsquo;s termination on account of Executive&rsquo;s Disability
under Section&nbsp;6.4, unless the Company specifies a later Separation Date, in which case, termination shall be effective as of such
later Separation Date, <I>provided</I> that Executive has not returned to the full time performance of Executive&rsquo;s duties prior
to such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;thirty (30)&nbsp;days after the Executive gives written notice to the Company of Executive&rsquo;s resignation, <I>provided </I>that the
Company may set a Separation Date at any time between the date of notice and the date of resignation, in which case the Executive&rsquo;s
resignation shall be effective as of such other date.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Executive will receive compensation through the
Separation Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In the event of a termination for Cause, written confirmation shall specify the subsection(s)&nbsp;of the definition of Cause relied on
to support the decision to terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.6</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Cooperation With Company After Termination of Employment</U></B>. Following termination of Executive&rsquo;s employment for any
reason, Executive shall reasonably cooperate with the Company in all matters relating to the winding up of Executive&rsquo;s pending work
including, but not limited to, any litigation in which the Company is involved, and the orderly transfer of any such pending work to such
other Executives as may be designated by the Company. The Company shall reimburse Executive for any reasonable expenses incurred by him
in connection with providing such cooperation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.7</B></FONT>&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Section&nbsp;409A</U></B>.&nbsp; It is intended that all payments and benefits under this Agreement shall either comply with or
be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (&ldquo;<B><I>Code</I></B>&rdquo;),
and any ambiguity contained herein shall be interpreted in such manner so as to avoid adverse personal tax consequences under Section
409A. Notwithstanding the foregoing, the Company shall in no event be obligated to indemnify the Executive for any taxes or interest
that may be assessed by the Internal Revenue Service pursuant to Section 409A of the Code to payments made pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>GENERAL PROVISIONS</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Notices</U></B>.&nbsp; Any notices required hereunder to be in writing shall be deemed effectively given: (a)&nbsp;upon personal
delivery to the party to be notified, (b)&nbsp;when sent by electronic mail, telex or confirmed facsimile if sent during normal business
hours of the recipient, and if not, then on the next business day, (c)&nbsp;five (5)&nbsp;days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d)&nbsp;one (1)&nbsp;day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt.&nbsp; All communications shall be sent to the Company at
its primary office location and to Executive at Executive&rsquo;s address as listed on the Company payroll, or at such other address as
the Company or the Executive may designate by ten (10)&nbsp;days advance written notice to the other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Severability</U></B>.&nbsp; Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect
under any applicable law or rule&nbsp;in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision
or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal
or unenforceable provisions had never been contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Waiver</U></B>.&nbsp; If either party should waive any breach of any provisions of this Agreement, such party shall not thereby
be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.4</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Entire Agreement</U></B>.&nbsp; This Agreement constitutes the entire agreement between Executive and the Company with regard to
the subject matter hereof.&nbsp; This Agreement is the complete, final, and exclusive embodiment of their agreement with regard to this
subject matter and supersedes any prior oral discussions or written communications and agreements.&nbsp; This Agreement is entered into
without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended except
in writing signed by Executive and an authorized officer of the Company.&nbsp; The parties have entered into a separate Proprietary Information
Agreement and have or may enter into separate agreement related to stock option awards.&nbsp; These separate agreements govern other aspects
of the relationship between the parties, have or may have provisions that survive termination of the Executive&rsquo;s employment under
this Agreement, may be amended or superseded by the parties without regard to this Agreement and are enforceable according to their terms
without regard to the enforcement provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.5</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Headings</U></B>.&nbsp; The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute
a part hereof nor to affect the meaning thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.6</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Successors and Assigns</U></B>.&nbsp; The Company shall assign this Agreement and its rights and obligations hereunder in whole,
but not in part, to any Company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company
may transfer all or substantially all of its assets, if in any such case said Company or other entity shall by operation of law or expressly
in writing assume all obligations of the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise
assign this Agreement or its rights and obligations hereunder.&nbsp; The Executive may not assign or transfer this Agreement or any rights
or obligations hereunder, other than to his estate upon his death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.7</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
<B><U>Choice of Law; Consent to Personal Jurisdiction</U></B>.&nbsp; All questions concerning the construction, validity and interpretation
of this Agreement will be governed by the law of the State of North Carolina, without regard to its rules&nbsp;of conflicts or choice
of laws. Executive hereby expressly consents to the personal jurisdiction and venue of the state and federal courts located in North Carolina
for any lawsuit filed there against me by Company arising from or related to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.8</B></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Counterparts</U></B>.&nbsp; This Agreement may be executed in separate counterparts, any one of which need not contain signatures
of more than one party, but all of which taken together will constitute one and the same Agreement. Delivery of an executed counterpart
of this Agreement by facsimile, including, by facsimile transmission or by electronic delivery in portable document format (&ldquo;.pdf&rdquo;),
tagged image file format (&ldquo;.tiff&rdquo;) or by DocuSign&reg; or similar electronic signature exchange platform, shall be equally
effective as delivery of a manually executed counterpart thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Signature Page follows]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B></FONT>, the parties have executed this Employment Agreement on the day and year first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FENNEC PHARMACEUTICALS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Khalid Islam</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYEE:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jeff Hackman</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>tm2421051d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="tm2421051d1_ex99-1img001.jpg" ALT="" STYLE="height: 66px; width: 120px"></B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><B>Fennec
Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director </B></FONT></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><I>~ Accomplished
Industry Leader Brings Extensive Commercialization and Oncology Expertise ~</I></FONT></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><I>~ Assumes
Leadership Role at Critical Time to Expand Use of PEDMARK</I>&reg;<I>, the First and Only Approved Treatment to Reduce the Risk of Cisplatin-Induced
Ototoxicity ~</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>RESEARCH
TRIANGLE PARK, N.C., August 5, 2024</B> &ndash;&nbsp;Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty
pharmaceutical company, today announced the appointment of Mr. Jeff Hackman as its Chief Executive Officer (CEO) and a member of the
Board of Directors, effective on or about August 16, 2024. Jeff will guide Fennec&rsquo;s strategic direction for operational success
in the expansion of PEDMARK&reg; use in community oncology and the adolescent and young adult (AYA) population. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">&ldquo;Jeff&rsquo;s
appointment comes at a pivotal time for Fennec as we continue to advance PEDMARK&reg;, the first and only therapy approved in the U.S.
and Europe to reduce the risk of permanent damage from cisplatin-induced ototoxicity in pediatric cancer patients,&rdquo; said Dr. Khalid
Islam, Chairman of Fennec Pharmaceuticals. &ldquo;We are confident that Jeff&rsquo;s deep expertise in the commercialization of new therapies
across multiple oncology indications, and extensive experience leading organizational growth and transformation, will bring tremendous
value to Fennec.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jeff brings to Fennec more than 30 years of commercial
leadership experience, including oversight of more than 10 product launches across a wide range of therapeutic areas and markets. His
tenure in oncology spans the last 12 years across Sigma Tau, Baxalta, Shire, and EUSA Pharma, where he was responsible for the U.S. commercial
organizations and managing the company&rsquo;s product portfolio in multiple franchises, which generated billions in revenues over the
years. More specifically, Jeff has successfully commercialized products that are specifically relevant to the PEDMARK<FONT STYLE="background-color: white">&reg;
</FONT>markets, including the outpatient oncology community and the AYA population.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;I am excited to lead Fennec and look forward
to working with management and the Board of Directors to bring this much-needed treatment to oncology patients,&rdquo; said Jeffrey S.
Hackman, incoming chief executive officer of Fennec Pharmaceuticals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Rosty Raykov,
who has served as Fennec&rsquo;s CEO since 2009, will remain a member of the Board of Directors. </FONT>&ldquo;Rosty&rsquo;s unwavering
commitment and leadership since 2009 has been critical to Fennec in bringing a much-needed therapy to the oncology population at risk
of irreversible hearing loss, which can have a profound lifelong impact on patients,&rdquo; said Khalid Islam.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>About&nbsp;Fennec
Pharmaceuticals</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fennec Pharmaceuticals Inc. is a specialty pharmaceutical
company focused on the development and commercialization of PEDMARK&reg; and Pedmarqsi<FONT STYLE="background-color: white">&reg;</FONT>
to reduce the risk of cisplatin-induced ototoxicity in pediatric patients. Further, PEDMARK received FDA approval in September 2022,
and Pedmarqsi received European Commission Marketing Authorization in June 2023 and U.K. approval in October 2023. PEDMARK has received
Orphan Drug Exclusivity in the U.S. for seven years of market protection and Pedmarqsi has received Pediatric Use Marketing Authorization
in Europe, which includes eight years plus two years of data and market protection. Fennec has a license agreement with Oregon Health
and Science University (OHSU) for exclusive worldwide license rights to intellectual property directed to sodium thiosulfate and its
use for chemoprotection, including the reduction of risk of ototoxicity induced by platinum chemotherapy, in humans. For more information,
please visit <U>www.fennecpharma.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>For
further information, please contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Investors:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B></B></FONT>Robert
Andrade</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fennec Pharmaceuticals Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 919-246-5299</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Corporate and Media:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B></B>Lindsay
Rocco </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Elixir Health Public Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">+1 862-596-1304</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><U>lrocco@elixirhealthpr.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fencf-20240805.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaONubOdzZR++YkxtmB/bflKfyUuEhOM6SzO3w9WwSsL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:fencf="http://adherex.com/20240805" elementFormDefault="qualified" targetNamespace="http://adherex.com/20240805">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://adherex.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="fencf-20240805_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fencf-20240805_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>fencf-20240805_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>fencf-20240805_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://adherex.com/role/Cover" xlink:href="fencf-20240805.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://adherex.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2421051d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2421051d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" '@# 2(  A$! Q$!_\0
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M TUM)M&>(^4A1&+E67=N)&,G/I4::-$LF1(RQAG9(XOD"[CST^G\_6I]PO\
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M4 %1;5-UN*C<$P#CD9/_ -8445$]D5#<EHHHJR0HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140043162652016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  05,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FENNEC
PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001211583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-0442384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">PO Box 13628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">68 TW Alexander Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Research Triangle Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">636-4530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares, no par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FENC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "6E099>, ;XVP$   K$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8;V^K-A3&W^]36$R:-JDMX/QIVB61*$UWH]NFK,E=I4U[X8"36!<PUY@F
M_?8[)BED%3GD38()Y^''\>$Y=H9;J;[G&\XUV25QFH^LC=;9K6WGX88G++^2
M&4_AEY54"=,P5&L[SQ1G41F4Q#9UG+Z=,)%:XV%Y+E#CH2QT+%(>*)(72<+4
M^QV/Y79DN=;'B1>QWFASPAX/,[;F<ZZ_98&"D5VI1"+A:2YD2A1?C2S/O;VC
M/1-07O&7X-O\Z)B81UE*^=T,IM'(<@P1CWFHC02#KS?N\S@V2L#QXR!J5?<T
M@<?''^H/Y</#PRQ9SGT9OXI(;T;6P"(17[$BUB]R^X4?'J@$#&6<EY]DN[^V
MV[5(6.1:)H=@($A$NO]FNT,BC@+HX$0 /030DGM_HY+RGFDV'BJY)<I<#6KF
MH'S4,AK@1&IF9:X5_"H@3H]]^<;5T-8@94[8X2'L;A]&3X1YQ?J*.+T+0AW:
M_7^X#005!JTP:*G7P3#(/]XRUPHFZM\FHKU"MUG!5.]MGK&0CRPHSYRK-VZ-
M?_G9[3N_(WR=BJ^#J8_O95A +6JR>,]X$QP>/KC\BD!T*X@NJN(!0512/,1L
MW42!QZ]8G'.$HU=Q],Y+1L"5D!&9I!&!XFO,"ZY4EE%91VV%U*_8^JCB)-5"
MOY,'$7,R*Y)E<W'C&H[C7G8HO>DA/-<5S_4Y/"]\+4QI0])F+&G,%*[S,)G-
M)OY/P1?OY<GS)]\64]][G)/IS+]"* <5Y> <2A\F5;&83-.([\A7_M[$B2LY
MD#SJNKU!!\&ZJ;!NSL%:L!V91L F5B)DI9F?GEI<D3J73K=+.P.LUERG-D_G
M',!I&DJ5256R79"YAI>!2$5\64!"(:\R:ISR%G7/Q2"/'-X]!]*+(O#%_.+C
M@#S"=>0Y;2;#)8-G<B=WQ.WTZ0!CK.W?1=T;9UQL92,C+MD?D,4K\6*^8U#.
MBMPK:/\8;-T+7-S-/\/Z9@33O9#;M!$4EWN!;L54N"$+)5BZ!N,*F/J.D=8-
MP\4=_S-I59F!DF\B#9OG'M><^1A:W4-<W/H_HP4RUV ]?XOL].N"*]+K:^<&
M8ZM[B(LW@')"/5CDGD;!!6Y<%*1N'B[N^H\RA)P$&YEBW:Q%I-_I7W9['0<C
MJAN%B_O[JQ):\Q02DR1%>K#CO)$*%VI;C+AUDW!Q3Y_+6(1"BW1-GJ"\X26*
M&WEPE38>6C<%BMMVH/AE".GA\'[MUXR\-*#GU:IY_EKT6LGJ3D!;;/LSV33/
M"R!K!<1E6P&/=@&X9R^$!ON3*^+27Y>_D3D/"ZBWQF5(BY*I3U@GY!L&]G)!
M4DDRIL@;BPN4M.X!%#?MA6*1J;CY>[*4C?76(@ +.LQ(:>WQ%/?CCR21R2[<
M0/_@)U>8+4(S;W[O_8DQU>9.SS+W2<+5VF3I#U#0&V,:&4N;IQ,7/%EB]M'6
MU_R-\,3,'7,2\Q4(.5?7H*OV._/]0,NLW TOI8:]=7FXX0S*WUP OZ^DU!\#
ML\&N_A\9_P=02P,$%     @ EI4&69^@&_"Q @  X@P   T   !X;"]S='EL
M97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNG
MLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[
MSC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPK
MH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP
M'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ
M#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#
MA\EC%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VP
MI!&/QGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\
MR-%8\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+V
MH_\W5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;
M^PO\*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN
M1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB
M*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z
M6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBI
MN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &
MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ EI4&69>*NQS     $P(
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M_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ EI4&620>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( ):5!EEED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " "6E099N*<0'.\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "6E099
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( ):5!EEXP!OC; 0  "L1   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "6E099
MGZ ;\+$"  #B#   #0              @ &P#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( ):5!EF7BKL<P    !,"   +              "  8P/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( ):5!EFJQ"(6,P$  "("   /
M      "  740  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "6E099)!Z;
MHJT   #X 0  &@              @ '5$0  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " "6E09999!YDAD!  #/ P  $P
M    @ &Z$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   $
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2421051d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://adherex.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>fencf-20240805.xsd</File>
    <File>fencf-20240805_lab.xml</File>
    <File>fencf-20240805_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2421051d1_8k.htm">tm2421051d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2421051d1_8k.htm": {
   "nsprefix": "fencf",
   "nsuri": "http://adherex.com/20240805",
   "dts": {
    "schema": {
     "local": [
      "fencf-20240805.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "fencf-20240805_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fencf-20240805_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2421051d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://adherex.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2421051d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2421051d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://adherex.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-24-086369-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-086369-xbrl.zip
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M?-W-@9&TQQB'<W" Y2@1S1PK8"E4$:B-ZR!;O80@-T)3UPHAT&L3S,'8GX"
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MEFYICGGQ+CFWC4R SBTY@,TF,88H(%+LS@!"*C%2:C\O:*OL$=4B2_WN$-A
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MCN>,;X,\53+UT=F0D!Y'=T'9)IJA>67;3YP/0TYFU3@/3( \NQA *]5@$?U
M=:S8PG&I ;MG">3;0^5;H:UAS.6Y<T]GS/GK7'%76^H.AL<%3Q$@^#[F2!%4
MBQ2!*R$RPN_I0JH:\/N60-ZO,'E7:4/"_'=&E*&*KR&DCXR!L%]CPO8H1.+]
MH(C0S/&! #^V!A+_ _7&PZ,1"?EX3CEW&1P1H%Y>90_$_B<F=K_.%P#^^LE=
MW^VE!<Y^IP@0_YN7@O](+5($[JAB,K&7= 5@?V0,I'Z&2=VC$)7WM4B@M+>F
MX/P''_:!/"340Z9CP@N/AO:8#N.N,(<B1\DY:V6B8O^7$@6&OF,,18Z2AM9(
M;!CX(%-JSYG@J.*WAB)'24#K1#;,_%H89M;ND?^7+)W\?'"ZS_K8"LH8)>GT
MB4)A6SYI$,;-9(3X'EI"&:/DFB%Q*)P'5H\B?"02NOI$UR'01Z90TB@Y9E >
M"NH[Q5*BUF,6UP\:Q[90V"B995@@"NT'LAHE5A6;LF(NL!ZZMPB4/4I:"9*+
M$H*1B*5:R)W'Q0.9V?-Q/9!)<$BO*0@-!TJ^^0SI*$&Y2A*+2V_^W#!!NZ%0
M5)J#YXCP A"0^4*P]YZ'O0?'CI*'ULI\(=C[S\/>AV-'R45K96)B']B/M^I!
M+CTST%YC*'*47+1&(B;P_$ISJ^Z4?&+%DJ@ZZD<EH.@14]2P6-0.7USD(;V]
MM(3R1DQ7J\5A<KZ3VA#^'UO4W4E6VT.9(R:N(:%-/V LXNX>6OB6$AV80/FB
MY*J5<II&ZB*L*/%WWWT+*%"4!+1*3,,\;Z2;^YA+$7P>>VP%Y8J22?I$-3WP
MNG7$VGOJ[WP-7L&&,JP>RF@8XW?%C/5@(-,T$YMG-)Y9,8\I%"]*^A>4US#J
ML>0L9H:)V6=[AZ@8X=6<J^R@D%&2/;^PA@G?*>HB3>UM=[Z.RVTT4+?3J6_D
M#=E#B:/D>O5"<<F/M,ZH>B[_BE+0**"D?5#138\S-,[LL+?N]B8/;L>,9Y0Y
MLH*R1DGY?*(:9OM%/BCBMNJ-U^E$<O_VD$I#*&&4!"\@K6'(>WY4XSTP@8)%
MR>PJY2"-"=>K>$[$C/I7+U1;0@&C9'HA<6AC[PPT]LZ>.?:B9'P^44ALB[7A
M]HRZG7 V(_Z=9,$"X'TVF,0#4IO>OY=O^7&;N%6:^S&T'ZJQ>TRAP'&V2(;D
M-8TZ2YBA2>'2D DB8IM2;?>U>;+S^E+0 .#LH02*1GF\_YUR_DG(I1A3HJ6@
M27&K'WK"[RT"C0+B'&*-7)00?),\LY14OA!4><X!CRD4.>+<H4<>SMK+8E'S
M]MI3O*TC1-Q7 @H><1(Q+!9I?9JASF?V1#\00S8>AOC[2D#Y(TXHAL6BK9]7
M WOAF<GPG/F!(90VXE+82FDHD,<IX?Q]IIF@.CBV'!A"(2.N>:V4A@+Y.J5J
M9@>UCTHNS7RSMS,$VU, "AUQ96M0*@[\U<]]Y,7^MR#Y"FOPVPD0L7M%8KUV
M(X[=0HKB2BX2HCS40_90[J@;*_U"&R9_:^94[=X_Y<Z,;-X66O107PH:!91T
M%2H:Y]JZLY,_>&G=LX/R1DQ,JX3A[)G*)IS%0RY)\+Y\SPS*%S$+K9"%@O<]
M$8\J6YAX?:=D3*F;/M';LPV0$ $K@(8$,3]]%@J<QP4R3=UF(AD_CN=6M+[-
M3/[R4NM?\*%!L!PT-)B;. '"D>Z"],^-7C1YO[ZG4ZK<,H4'NC+O;4./X9LB
M0'%H?%#?* 3&4!&FB\Z1KAM[P+V>MOC&_7*O8+5'_@=02P,$%     @ EI4&
M61Y]PYAQ&@  KX8  !(   !T;3(T,C$P-3%D,5\X:RYH=&WM/6U7XLC2W_D5
M_7#OWM5SY"4!%-3A.8CH,(ZOZ#@[7SQ-TD T))ET$/#7/U7='4@@J'#%<>?9
M/;LK))VJZGJOZDZS_[^CODT>F<\MU_GTIY;-_TF88[BFY70__5EKU9O-/_^W
MFMKO!3 ,ACK\4[H7!-YN+C<<#K/#0M;UNSFM4JGD1C@F+0?MCA+'Z?F\EOM^
M^K5E]%B?9BR'!]0QV.0AVW(>%L/'NY.A;=^V8D/Q2HBDD)L##7?-Z0/1P=LY
M>3,V-$@<6I)#@W"HQ=VBKNT\1X<<,7E@M&BLAC3##-GW@ZNOT^%!\OCIT%S@
M4X=W7+]/ Q A0BIE\GI&WXX R7!FQ #!]VS7?7P13CE3T$(X<\*)SQ1OMRF?
M<-QD,^P.<<(->$(OA -]UED(=CL'=\.! Y[I4NI-!G<H;XN!ZD8,*ESS79OQ
MQ-'B3FRXX0Z<P!\G4ZQNQA[@?C /&B[&!G7 E*:3HV:/^6R4-=P^CBKFR_E2
M&FV+4;.:(OC/?F %-JONY^3?U'Z?!93@\QGV<V ]?DK772=@3I"Y'GO :D-^
M^Y0.V"C("0/,P5,Y"7+_?S(9<F0QV]PE+1;LD3/:9[MD9([V2/-0?+C+Z_6[
MF]8?^N%QK78!?Y!\DLF\\N%"\4[,\2XRM[MP;J\'4ZQ/'EKAZ5+ECH%2 ?'P
M;ZW/'!/^"XYLVKWK4)NS)2 5(Y :#@AA7 =0/K6;CLE&)VQ\EP<7IFM:J;P$
ME[8/@,6'=]J=\@82/EQ: H1^U^I1G_$[_4[X/@F#BVM+@#E$2BX4J,(<08M@
MMUUS3'@PMMFG= =T;I=H>2\@UU8?1IRQ(;ER^]39DA>V +]O=5"U3>LQ?,RT
MN&?3\2YQ7(?A/6NTBVK*?-!]\<4R3>:@(> W&'4VZ ,<0RKY*+A"/U'CYQW4
M$'1-8#W$,C^ECZ@1Y/$?L#L')@VXF+4;4X1T56C"?BX&^;_!58SB2E25='6J
M*TF(<]$Y(QG@ZL"&(&AQ<1\=ZBX7D1+((2+\[?:$MQ0VEPDM)3OB9EK=#\ M
M?$ISJ^_9#%V!PA,#+7%Q=^ K5#!(R'U7S5[,=&;VRD&%(YF8<7AQ<MDR\4;'
M8CX1E+/$J%-OGL29,_OP!%DN"9O"Y0$G77..!(C[?G!( U:=4A_"F=Z;?0IT
M9<$SX9T9DJ+8PVN*?3&6#AQ+\A.L:Y:)?4;YP&=5986[,"0$%=Z*P4=8R<"E
M02^"KR8OQJR(8.HU9I& B8/@YAB*3PIMIX'K3^\N/?=9\A)@1C >,L?M6\X+
M.%_DQRS2!+#A[>CT9]FH3&]J:=+FE=/;S\&SU50JM>^%/K)/_:[E[))\NOJ?
M?VG;^;W]G <CHJ[]:F"SS 7MBJ@6]:_RV4S@>O#\'E%?VVX0N'UQ96B900\=
M=_Z/=.S)MNL#0?+) YL:#T0'W\Y=VS+WB+H9PI'WM>E]C 89;CU!J(&K4[IQ
M;NK_$>IS,?(73%U-VELVX(23!B P%&:,QIBAMM6%2P;X$.8#\/:$Q/8B3/I;
M8;HY:UXW#DGKNG;=:+T'PE:C?G/5O&XV6J1V=D@:W^N?:V?'#5(_/SUMMEK-
M\[-GJ'@S!M]2WH/Z,7#A^<-L/4MTR*PJ[X'Y_41[!)42V><>=81_Q.RJDB^+
M]#&3.72- :8>F*3?&9/4=IKD/M5.[2O3+!=^'/< W(HY2"6:@T1QIJOES,EL
MSK&?0VJK'T(,;X:I/O AKPG(%?-</W@/C!<#GP\HH Q<>-# 8EE.5RL0UR=:
M:</<)&Z'!#V6@OL#WPHLP-H8&3WJ@-^K&0'>UBJ%XN\E"LR2<&92%&0C_,XH
MQ$3& \(>45*^N,W,S=W4K/D<S)C/A<BQ&C(!2[:C0EL_*][_U$],8RD[DHV.
M3VEK%.R: +T/8WLF'8^!6N;$[4S+)]E9C+ATM3;H#F".I2V":/X?V-Z,[ Z5
M[&0I=,6Z%L>.4H!5:++H_)M;[9)].[NM@Q^+D!AF$T5,)V!"*WI'39NOT.)D
MI:M'C;.S1CUU\;EV=5JK-VZNF_7:UQ9IGM6S\Q)L3Z6X1KYN-$8P 4$Y&H\_
MH9A03KC'#"R03&(![P-.P*> +?F;:R4IEHJN36]G%4J/*=2193,019OYR<IT
MSGKG-\UV_]3NKAQ/-7U>8Z9XL6+5,@5=KY1^E75OU-U^W^+8JB=(&)&4O:/T
M ]H&M :S;9BQ@6L$:7".^-VCIAE^7YJ,2&DRJ3@,U[:IQ\$3A)]$Y;D?J!)L
M/S!#1(_,#RR#VB'I4,E,8!8K?\2+%"#GU3I8B.E@TS%<'X*7:)"W G#[==D8
MKKOF A]WXY\_67QXT/[)5@U/V+O?96:7^I[O/JI6]%R(*LRK[K/DIJL'F)CP
M'JF[-FB11;=(G3K4I,\J=V"^R'Q9*4[XK\^S?ZI3KP#W9K*LQ61Y34=-U6XR
M!(.><R[E&Y_WKH^OOW3MU9U+0L-P 1'IJI[/Y(M%O5!^/I$ ]L'__"7,0C5O
MUN6?A)9A%NQ"]NN3>TA^N6F)'!F"F? A:T1O115>.,6E%/:_UM)7:>9&,WN5
M;65)H^_9[AB8%-< <N9F-^.2S0FG6WW/E/%OZ>;7J]L)'J48\R@UT_09Y^K/
M5\MA6K(WX=[)4XEO]^S3U4M_K33O31((2%<OSLF!.R):85LO+_ E6W-MC(,7
M)J8G3VQ\_%WK>\?'@V_%U2>V_9J)Z>GJ=IE<WY*:S4;4 3TBA[[U.+>^$\YP
MHMKOJR!:$A_K\/'<OW:'3C(7#W[\]:UP_+D\]K97Y^+.0BY.T:>K5XQ#N6OT
MR+5O4:<+)G]!_8=7JTD]:7HB!)S[%Y"K@#]>D!:-]?;VP#6_UGZ45Y]C>>$<
M9VA(5\_J+Z3L'R"S6;O[FO'R[VL*A21=N7!Y0.T?EK<X@1[_I/3DN'M@C JK
M:TIEH:;$*("\:V<G7WF-JBR9=KTV-U!48>'O^:"ZED=MPD;,& 3@W> RI F,
M;W[$M 9X2)")ORAY>;\VY[2'])]_E75M9X_#2)MY/==AQ!$)_!8!V=D#3)12
MU&<4--5DNT@< 0 ;L[9QI&P#77,-AB^VAL;I]](]M^KE(W-E:]!CW<PHSG2U
MHBW2_LTY[Q_64U]=4)@+G/US)=1%O_EY^Y Y)]]6CVIZK*,WBQ=2@L)VIE@J
MY-??GEEK3^Q^P*$>&*>K]1XS'G =@5 /:G_P"%A=M2&=:S/;'1)++#(0L1)5
MSIR0CF6#QA&+@_H%#+(B,Q6XA%O]@1U0A[D#;H\)AS*#=\;B2?6 VP;$5!5I
MXD:DZS@0V15UQN&]#J3I[A"?PWZ$A<THOKL>OD[+D&C9,5N6K(CRU2OE@?^L
M>TP472KB5!6TO.6D<]6$ZUF]9#EQ.#;K!&&+/=H9[]"^98]WR2W,'?G!Y_OP
M8>Y^ZUL!* %V# >.*B[Y@B95=WQNWFKZC;Y<-A9=0VF[KLVH(W99S5AMK*N:
M2)84>WEOH>&J/QA8IOQ+9+R"#W1'$1 OLFB'6Q"DFA7UDM)O5.SI8ET*U^@V
MM!U2/[HB>B&?A8$JZ(K -HEJ_ZC\1U#Y':7R+=>V#!"@TST%1PG>TD[6=W.P
M4WXHU8_KQG)UZBOU/=:*G:?I#95]"APD*J$OT'2M2#.:'E'V<#DZKNK%?%:.
M_$?;/ZRVAP[^PF?H17%3I]CV@0'?/^]T%F5@!?.I/3)O[<IXY:6(Y[0^UMY>
M3-L;:C\@R1@1+*_S^5K1S.@;[<W4O"V0>5N08_^QA@]K#>5D:VAR/F#^BS91
M/K;'MS?#?NM^N5;L*VVB](Q-S%'XZRVCP#+%#>-UEJ'&KLLRE'Y8#BZ.A$KS
MQE47Q,_I]BQ9\3"?F3'NJ U>!&*G*G^ $V]5[2PPIH^WX/Y\BRD]UT:*;BAN
MSVX8GME0O.@^^H2$NXKP0@'H5AR0>+2LAKVI\)IO=7O!W%4)5%U,ZN]<XVM7
M<M.:T2.&33E/;)2]PPR+:YJA3W$@X>-^V[4W%C03)8E)U/6L@&50%QF^R3/T
MJ;=VH9RIO5!")BQT26"50(S1PRY<H;*WW_9SU=34C&?;M"OJ\(I"7 ,79B-?
M/JQZI!,;:WI;:.^"S7;WE_<G/T\O:U\JJ_??8FMSLWC350QO(!7Y7L46: =,
MSB>/U!XL6IA[SK8^+N?#G$.94DM84C+;Z]\NCW\6:GG-HZNS/;:8%T,J=C N
M7MM:S%S%B3=V7>_(^U#[P@QE\3;3R\/&E_OOE:OA<@M(<SNP !%*87;GE5Y.
M,HHH6>C N$E_+A 3J5//"J!R/Z7^ PO>9?DD.==8$XZF8V+FR4A[3 S1TH:G
M'L!Y,[%):*;?;'$" H>T%0%W2==WAT$O!0FLASUHRHG).I8C=\!B[DJ*^5*8
MFT7RN>DN^P+9P%GN[(E&7CC8$GMG/=P[B_N5!"3P9!D] 5:L5Z*V[D^ 8C(\
M?2X"-OLAUQI*VVAKXJ-6R.JS9B>L-%UMQ-E/0O8O4:(M6<?%MX^'^(\%^KK$
MGFS>3KY]8]'>T\GWY9;$7EG")2P=)Q+WVNKM+3>0OY/Y=A(,,M0(7.E,M&YK
M=B$IU0/;93;44V"[CBNJJP%G8A2@%<M51)Q!88F*2[Y?BV(2N.PQ(A]:@!H5
MT8$9P1V?/5H<G@./0!T#VY_4$#MD188;4,>DOLGE0I49*>U2T=*NL$'#%W9B
M!6_V#=4]5(XU:,%K2N5EWQ\MH%^8:11IPEDL\1+IXK1B[B73MWJ)=&5#>C.+
MG&<XTKD'HW\.L!T#0 71(BV;9]_"UVRCTI&2F!'/MGA;QDOJ"\E<*F$C1ZPS
MF !3;!>1>U[$J\IS1/N,/F3:#(P48'IBHE&8VPO4*$IHA']1I8UBC(K^3:7^
M]^FT1+9N)W14=T1'=6ZCSV+/] +-\Y#:U6; ^I)?I6Q>S\9>ATJH,Q)"R;HI
M/&10;@8#7_0*#BT?_+OK<PP3=> FA7SQ7.R?\OD>:=@LW)4^';I':I[G6DX@
M>J9P9_XYC/;,X7@0P)C4?!]C!8[F2</GF/1.:?U,1-!WLJ6X<:TO63AW2/Q%
MR"URQ!R'&>2B1R'A,MA Z#4G3<?(AANH4AL8>]-A*K4)(=Z!*&Y@1@ WS*A@
MKUQ Q6WZ2*[H^,%])!W?[1-,O#U7I0Z0:.!C"MQDEU:]9[$.1/AP-YT24VH#
M1^CYO7KC7'S2]C:SY-3/A@@P<>',?P1JX!., O+@(^DSW'849@ZSV-HNI!YX
MTYQH8HCH &^%J$2&HY52^.(IC^$=6K8-&4X?5>HE; +D6U4<O[16Q*3=4<8I
MTKTI1R:SG2A$2@ID"YN!LWH789,06(2S(AZ*$A+R0 JCG(X\>P82R!;"EINA
M:EV?R?63Z)* :#IN$=IW<>L4EK I@-:'P@_0P[S!,:!(P:_1R?-A;8BG\\Q0
MAF-,A N9*Z3'/J;2.."1<9'%PJ.&\BNN)Y=O>A *,=V.S B>!QHA=^4L-?#P
MJU[1MPJEBECZF33E9M2'T "F/V18]*%V0]3!\.I!X2)L[=_@.?)Q6W!MR*>U
M8GEK.U\!Y83<WA(9O8!/\. 3+CF4@BM3_85_.P/X"IP!T"@.UNF E,5'H>@X
M7QR&";QOXM%]4OQ(K@ME*63X-I&,'O88C!N"QC-SB_"!@:-P*@!&S5. ;&/]
M 84=5 @IX25">E&XP+\:3-0FA;S0F)TWLAXMGRVJ OM7&M**D14]>.IY2XIZ
M9AJ/EU] J#X;DU:6?(;\M4^=YSRF]%E$!<AK/#^.H!(Y8 N1R)H"8Q(KDJ*>
MPW(*!!L,&>@ *N8$$6+ 78JBJ035(\<B<M9N8X\,@3@U@XEOS\9&H.L'<B3K
M4J!,<@&U9WE\6HM*C+.[M'U,/$+?/V-W24@"F!5#0WET[4?9WD+@ B=6KG)"
MHD"F0H-Y:F(?H7"$%0S= ;@''X\+!&::%C=L%T\V4IM_,(\CQ7Q1%;U7K#N0
MLR*MS,GO90,1)H._!L>VK6^1MB]4J \E"_++217R1,1>X6EQT=P7C01;G-*$
MH@;18C,"JS?4HPC#(_N\B2O.4 5'BG FT&$NV'TP!^#J; J&TX-)4<-W.4?/
M"U&'"$U/207QJ2<2)+0#5$[0Z;[H"D-F\!GC!W-0DA@+'"@=W.Z8H/'(?,>F
M8+2:KF:CD+2L;I^2:SK8(@=T1.V  @M[H!E; GKCIE53J=D6^E4(J0 )#0-\
MI0=*9F%1A/$,,=S@BXL1'KE^ESK6D]I5(*EUJ&@3X>,8Q1_99/YX[$<'JED7
M]R<3W)1L>0@<&&! <$3A2AOM,D?$03/5!C<N8,,#/AX?,F""T8*:,&-"7JN#
M$2"SM$$JL]8%(<)@G&,$&D?HA_+!#*GC*H3,P!(!Y%%UC!#I1>/PM'9ULL\'
M'NKP3A&;.O YE%-4)43H&@0>\$<XR%!D:C=&(/,2L:G@KQJPQU.6^'M9X8*4
M3LEG4@)$0PGP6F1UV!J,I6K8A\379L6H:7HUYPAE<H'*1X5=QR-:-HF ".34
M%+)<C5!Y.PTRF%>HS'V*__>2U]O5Y!>1;BM*1V9O*A0F"7(K43 6F IZ&SQ<
M&/./@;)<3FU,ML-43^2ROCISZ-^E4GXKG\]C>MB^QT0S<%/8+0;BT>C 2-'#
M,ED]!C /X=KQ;WL<4R5UT IW;1E,?29,E'QF1&:X;:&DN (NTG@(^$PHGJ-H
M)0$PG048P<6: X215-MU!E /(AZE6S&N"[F8S%"OLN_*T(TG-:>KUQ+: 4)0
MJ=.DE(2)=ZP.^!7 A4T_LE'*_R$N)_%5\%,Q$1Z T)$1IR"%K?<-Z8W[=)QJ
M"R^>$4Y953=C7-P7<E'# 8N-[Z[)L*=+514 ^>:60&:2@8?E.=1OJ IXGJ+*
MQ"?I8*@=%"("^/LPL72%#(&M''4)J.' @H6B$Y"VIEU_X=FC,:&/SD!5)E(/
MQ2C?'72E'_&HU$Q35&,"(P,S$<%P*N,4#HW*(TO V6&S$.<5SYN%EG;%"F>4
MDF)>J.FDM(O4<<]7;E(V&]8F!#B@!#WC"*,:#\LWE*@LRB 31"V4-JC4[8A:
MOEIP)M]P@T;HU#;B*ZRS?09PGWG2@-02E*SIH(ZAKE_8U-F$9RUK,X7D@(A1
MP()FR&E50@)FYSHL X6PE+.<@C0B4?WA"W0XEM!.H&*\J>P9/TONA2&S#8HK
M,C),6F!$!(Y0.LC7Q2T)2V0P0U>1@F(73!%N0%09,AV"&0!'D6DBJ1\B.Z<.
M).+$<#!$-2EI+M41TIL>@D[HSZ24I2:S;][CQKPHS'-2)?U6D>;Y*#P-"RF9
M$&(ZIFQ:96M61S3^(L^('%FZ%F:*O  2L%#IZW3 %RGZHI"T*?56M'DB A=Y
MHGB3SL(>1-";J4;#YH>*!:@AV%QQ#!D8^KA&.35,T1I"$(8ZS3#JFH6[G3K9
M%)2^4""2#4W?E)H.3!>.-USO%-/&1HTH=(3FTY&8!G=%VL[5)A5T-9X+B??O
ME<!<BY<4?=9U,0D'93%\RXN^W1CM]Z42^WT@#Y2-/&I-116Q"LTP'N )V0F@
M$EN'X%?@26\\=7B84@8!!#CL.02D,>I9;2M06[#S64UF2S J?K0EMC@G;WJ*
M% ;]6'C@C21S<LHW0<]G@=MXD1?3=GACJOT3ZE.O9L3S<%[@ @^Y@"JDDV0&
MI%9AP-^_(_[R@K+^+@O*KUBG_6U6AO_V&_,_QG(Q*6?SVDL+Q<^>+K&&HA1H
M.Q<-6Z3PERW1_K+5V%AIBZ\@85_>PT-'4FJM)&SQ8\!X;NUMX3*K:O<G97?1
M)D_RRD JLC)0F\0,49.)DU%"(A?$CTHEJRV(']$ NM:X\ N7WS'<6\[D1YS$
M!D@Z37&!)Q.[C)Y1,L_>"6\QC@;N%O*[S5 E.@/?L;A@NV.J/%>N7H!J0+ W
M5;W<L6S5*Q#05::)PHP?FEV>WW";2CHK.]8MB0X(NQ];N."R."%0#<1Q>.A%
MTGO_L5W#KI^:W1&X!4_)5!O7'*$PY"((!R',F<YQ^),KDO/OHGO_!*FE@U3E
M8P:IH\F65G&:F=QD))9LI*M[C] E_E_4LN7)E$.GEI%7_U&W5XMTP]S\2!H6
MT:)U:M#OHB":V.[\=O;]VFY_F-><N=F$]\ 7$%M!-JS;0[UV!H?3GD/2F^S+
MOZ#YW/EUST;$%='M4R)_="WHZT5=RY<T4[MCHTHEHV5[07^BKOB66 ;P^]0
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M[.Z($5A+U15"###^#)MV@I[@4/_#'[6R7(S$#P<%R]&::SD'WWT:]ORQ6PV
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M'-"%/A^D3M@-(CJ/++P[B,-M?"?<-?3-N'(I8U*9*;&!OM*QG]^]!4$2.!)
MH6+/BT(L;YY?2E F!_T>$$^<UDFK8 N*]?R2G"DN=)YG],4Q:1A/?GH8^IE
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M+3(P,C0P.# U7VQA8BYX;6Q02P$"% ,4    " "6E099->S[6ED'  #45P
M%@              @ &,#@  9F5N8V8M,C R-# X,#5?<')E+GAM;%!+ 0(4
M Q0    ( ):5!ED>?<.8<1H  *^&   2              "  1D6  !T;3(T
M,C$P-3%D,5\X:RYH=&U02P$"% ,4    " "6E099!K/56 ,9   L>   %@
M            @ &Z,   =&TR-#(Q,#4Q9#%?97@Q,"TQ+FAT;5!+ 0(4 Q0
M   ( ):5!EE8EJY<42P  %3F   6              "  ?%)  !T;3(T,C$P
M-3%D,5]E>#$P+3(N:'1M4$L! A0#%     @ EI4&66N"C=J\"0  V2,  !8
M             ( !=G8  '1M,C0R,3 U,60Q7V5X.3DM,2YH=&U02P4&
/  < !P#4 0  9H

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>tm2421051d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fencf-20240805.xsd" xlink:type="simple"/>
    <context id="AsOf2024-08-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001211583</identifier>
        </entity>
        <period>
            <startDate>2024-08-05</startDate>
            <endDate>2024-08-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-08-05" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-08-05" id="Fact000004">0001211583</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-08-05" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-08-05" id="Fact000010">2024-08-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-08-05" id="Fact000011">FENNEC PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2024-08-05" id="Fact000012">001-32295</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-08-05" id="Fact000013">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-08-05" id="Fact000014">20-0442384</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-08-05" id="Fact000015">PO Box 13628</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-08-05" id="Fact000016">68 TW Alexander Drive</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-08-05" id="Fact000017">Research Triangle Park</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-08-05" id="Fact000018">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-08-05" id="Fact000019">27709</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-08-05" id="Fact000020">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-08-05" id="Fact000021">636-4530</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-08-05" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-08-05" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-08-05" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-08-05" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-08-05" id="Fact000026">Common shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-08-05" id="Fact000027">FENC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-08-05" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-08-05" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
